Clinical meetings

← vista completa

Published on October 1, 2008 | http://doi.org/10.5867/medwave.2008.09.1717

Positron emission tomography: Updates

Tomografía de emisión de positrones: actualizaciones

M. Josefina Jofré M.

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

M. Josefina Jofré M.

Centro PET de Imágenes Moleculares, Servicio de Medicina Nuclear, Hospital Militar de Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Jofré M. MJ. Positron emission tomography: Updates. Medwave 2008;8(09):e1717 doi: 10.5867/medwave.2008.09.1717

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/10/2008

Index

Metrics

Not available at the moment.

Notes

References

  1. Fletcher JW, Djulbegovic B, Soares HP, Siegel PA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008 Mar;49(3):480-508. | CrossRef | PubMed
  2. Larson SM. Practice-based evidence of the beneficial impact of positron emission tomography in clinical oncology. J Clin Oncol. 2008 May 1;26(13):2083-4. | CrossRef | PubMed
  3. Maldonado A, González-Alenda FJ, Alonso M, Sierra JM. PET-CT in clinical oncology. Clin Transl Oncol. 2007 Aug;9(8):494-505. | CrossRef | PubMed
  4. Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. | PubMed
  5. Bunyaviroch T, Coleman RE. PET Evaluation of Lung Cancer. J Nucl Med. 2006 Mar;47(3):451-69. | PubMed
  6. Ost D, Fein AM, Feinsilver SH. Clinical Practice: The solitary pulmonary nodule. N Engl J Med. 2003 Jun 19;348(25):2535-42. | CrossRef | PubMed
  7. Gould MK, Maclean CC, Kuschner WG, Rydzak CE and Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions. JAMA. 2001 Feb 21;285(7):914-24. | CrossRef | PubMed
  8. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, et al Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007 Feb;48(2):214-20. | PubMed
  9. Yi CA, Lee KS, Kim BT, Choi JY, Kwon OJ, Kim H, et al. Tissue characterization of solitary pulmonary nodule. J Nucl Med. 2006 Mar;47(3):443-50. | PubMed
  10. Jeong YJ, Yi CA, Lee KS. Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. AJR Am J Roentgenol. 2007 Jan;188(1):57-68. | CrossRef | PubMed
  11. Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol. 2004 Aug 15;22(16):3255-60. | CrossRef | PubMed
  12. Comber LA, Keith CJ, Griffiths M, Miles KA. Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET. Clin Radiol. 2003 Sep;58(9):706-11. | CrossRef | PubMed
  13. Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non–Small Cell Lung Cancer: Dual-Modality PET/CT in Preoperative Staging. Radiology. 2003 Nov;229(2):526-33. Epub 2003 Sep 25. | CrossRef | PubMed
  14. Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptakethe role of PET/CT. Eur Radiol. 2006 May;16(5):1054-65. Epub 2005 Dec 17. | CrossRef | PubMed
  15. Shon IH, O'Doherty MJ, Maisey MN. Positron emission tomography in lung cancer Semin Nucl Med. 2002 Oct;32(4):240-71. | CrossRef | PubMed
  16. Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, et al. 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):463-71. Epub 2006 Nov 14. | CrossRef | PubMed
  17. Bruzzi JF, Munden RF. PET/CT imaging of lung cancer. J Thorac Imaging. 2006 May;21(2):123-36. | CrossRef | PubMed
  18. Vansteenskiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verbeken EK. Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective study. The Leuven lung cancer group. Ann Oncol. 1998 Nov;9(11):1193-8. | CrossRef | PubMed
  19. Seltzer MA, Yap CS, Silverman DH, Meta J, Schiepers C, Phelps ME, et al. The impact of PET on the management of lung cancer: the referring physician's perspective. J Nucl Med. 2002 Jun;43(6):752-6. | PubMed
  20. Kalff V, Hicks R, MacManus M, Binns D, McKenzie A, Ware R et al. Clinical impact of 18F-Fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol. 2001 Jan 1;19(1):111-8. | PubMed
  21. Schöder H, Noy A, Gönen M, Weng L, Green D, Erdi YE, et al: Intensity of 18Flurorodeoxyglucose uptake in PET distinguishes between indolent and aggressive non-Hodgkin's lymphomas. J Clin Oncol. 2005 Jul 20;23(21):4643-51. Epub 2005 Apr 18. | CrossRef | PubMed
  22. Isasi CR, Lu P, Blaufox MD. A metaanalysis of (18) F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer. 2005 Sep 1;104(5):1066-74. | CrossRef | PubMed
  23. Rigacci L, Vitolo U, Nassi L, Merli F, Gallamini A, Pregno P, et al. Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Ann Hematol. 2007 Dec;86(12):897-903. Epub 2007 Aug 16. | PubMed
  24. Zijlstra JM, Lindauer-van der Werf G, Hoekstra OS, Hooft L, Riphagen II, et al. PC.18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review. Haematologica. 2006 Apr;91(4):522-9. | PubMed
  25. Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007 Feb 10;25(5):571-8. Epub 2007 Jan 22. | CrossRef | PubMed
  26. Llamas-Elvira JM, Rodríguez-Fernández A, Gutiérrez-Sáinz J, Gomez-Rio M, Bellon-Guardia M, Ramos-Font C, et al. Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):859-67. Epub 2006 Dec 29. | CrossRef | PubMed
  27. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004 May;231(2):305-32. Epub 2004 Mar 24. | CrossRef | PubMed
  28. Kantorová I, Lipská L, Bêlohlávek O, Visokai V, Trubaĉ M, Schneiderová M . Routine (18) F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med. 2003 Nov;44(11):1784-8. | PubMed
  29. de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ. FDG-PET in colorectal cancer. Cancer Imaging. 2006 Oct 31;6:S71-81. | PubMed
  30. Buchmann I, Henze M, Engelbrecht S, Eisenhut M, Runz A, Schäfer M, et al. Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1617-26. Epub 2007 May 23. | CrossRef | PubMed